News

Prostate cancer is the most common type of cancer among men globally and the second leading cause of death for American men.

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.

This week, Marc Roth, MD, medical director of gastrointestinal oncology at Saint Luke’s Cancer Institute and interim chief of medical oncology, is breaking down these latest advancements and what they mean for patients.

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

Dr. Todd Fristo, a family medicine physician at Saint Luke’s Primary Care–Independence, shares vaccination information and measles symptoms to watch for.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Amid a measles outbreak in Texas, a Saint Luke's doctor discusses potential risk in Jackson County and explains protection provided by the measles vaccination.

Dr. Dawn Jones joins Health News You Can Use to talk about recent advances in breast surgery for patients with cancer.

After discovering she had an uncommon somatic gene mutation, Laurie Hamilton became determined to help those after her by participating in clinical trials and investing in scientific research for advanced breast cancer.